Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB05705ExperimentalSmall molecule
ALS-08 is a proprietary creatine-derivative that is being developed as a potential therapeutic for amyotrophic lateral sclerosis (ALS). It is being developed by Avicena Group, Inc.
- Primary indication
- Investigated for use/treatment in amyotrophic lateral sclerosis (ALS).Curator reviewed
- Code names
- ALS-08
Which companies are running trials of ALS-08, in which indications and phases, and which of those programs are still active?